Conditions: Aging Skin Abnormalities
Keywords: Polypodium leucotomos, Ultraviolet Rays, Heliocare, calaguala, anapsos Skin Aging and Damage
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 10
Healthy volunteers: yes

Brief summary:
With this study, the investigators will like to determine if taking a dose of the study medication, called Polypodium leucotomos (PL), prevents some of the changes in the skin caused by the adverse effects of UVA, a type of ultraviolet light.

Detailed description:

Arms:
arm 1: Subject is given a 7.5 mg/kg dose of Polypodium leucotomos. arm 2: Subject is not given any treatment.

Interventions: intervention 1: Polypodium leucotomos
Intervention descriptions: intervention 1: Subject is given a 7.5 mg/kg oral dose of Polypodium leucotomos during Baseline visit, and again at 8 hours and 2 hours before the Follow-up visit #2.

Protocol document: